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Abstract
Objective: Persistent adenoviral shedding in stools is known to occur past convalescence following acute adenoviral
infections. We wished to establish the frequency with which adenoviruses may colonize the gut in normal human subjects.
Methods: The presence of adenoviral DNA in intestinal specimens obtained at surgery or autopsy was tested using a nested
PCR method. The amplified adenoviral DNA sequences were compared to each other and to known adenoviral species.
Lamina propria lymphocytes (LPLs) were isolated from the specimens and the adenoviral copy numbers in the CD4+ and
CD8+ fractions were determined by quantitative PCR. Adenoviral gene expression was tested by amplification of adenoviral
mRNA.
Results: Intestinal tissue from 21 of 58 donors and LPLs from 21 of 24 donors were positive for the presence of adenoviral
DNA. The majority of the sequences could be assigned to adenoviral species E, although species B and C sequences were
also common. Multiple sequences were often present in the same sample. Forty-one non-identical sequences were
identified from 39 different tissue donors. Quantitative PCR for adenoviral DNA in CD4+ and CD8+ fractions of LPLs showed
adenoviral DNA to be present in both cell types and ranged from a few hundred to several million copies per million cells on
average. Active adenoviral gene expression as evidenced by the presence of adenoviral messenger RNA in intestinal
lymphocytes was demonstrated in 9 of the 11 donors tested.
Conclusion: Adenoviral DNA is highly prevalent in lymphocytes from the gastro-intestinal tract indicating that adenoviruses
may be part of the normal gut flora.
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Introduction
It has long been recognized that adenoviruses can establish
latent infections in cells in organs such as the adenoids and tonsils.
An adenoviral infectious episode typically resolves with the gradual
reduction of the infectious viruses that can be detected by standard
virological methods as was initially documented by two prospec-
tive studies [1,2]; prolonged excretion of virus lasting for years was
consistently observed in a minority of cases. However, it has also
been known that even in the absence of active disease, viral
dormancy can be demonstrated frequently by prolonged culture of
tissue explants [3,4,5,6]. In fact, the presence of adenoviral DNA
has often been demonstrated in adenoidal or tonsillar explants [7]
or T cells [8] in the absence of recoverable virus. Evidence for the
presence of latent adenovirus in these tissues that could be re-
activated by mitogenic stimulation of the T cells has recently been
shown [9]. Furthermore, life-threatening adenoviral infections are
a recognized complication following transplantation and are
thought to be a consequence of immunosuppression induced by
drugs that are routinely used to reduce the chance of transplant
rejection, and are likely to result from the opportunistic replication
of adenoviruses already present in the patient. However the
location of such repositories other than the oropharyngeal immune
organs has been hard to document; circulating lymphocytes in
normal subjects have not yielded detectable adenoviral DNA by
PCR-based methods [10,11], but as mentioned above, such DNA
is easily recovered from patients undergoing immunosuppressive
therapy or in HIV-infected patients [10,12,13]. It is interesting to
note that although adenoids or tonsils yield species C adenoviruses
almost exclusively [9], species additionally identified in immuno-
suppressed individuals include serotypes belonging to the other
common adenoviral species such as B, E, A and D; HIV patients
appear to be especially susceptible to infections of the gastroin-
testinal tract by species D adenoviruses [13].
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the possible immunological consequences has recently come to the
fore because of the hypotheses that have been proposed to account
for the apparent trend towards increased acquisition of HIV in a
vaccine trial (STEP) utilizing a replication-defective recombinant
adenoviral vector [14,15,16]. This trend was most pronounced in
the subset of individuals who harbored higher levels of neutralizing
antibodies to the vector (presumably due to prior exposure to the
virus). One favored explanation is that the vaccination of these
individuals with the adenovirus vector resulted in an expansion of
the adenovirus-reactive CD4+ T cells population, including those
in the mucosa of the rectum, resulting in a more favorable milieu
for HIV acquisition following rectal intercourse [17]. The
submucosa of the lower gut is a very large immunological organ,
and it is certainly plausible that a systemic response to an immune
challenge, such as an anamnestic T cell response, may result in
increased numbers of such cells in the gut mucosa.
Because adenoviral vectors are now being considered for
widespread use in gene therapy and as genetic vaccines, an accurate
assessment of the true incidence of latent adenoviral infections as well
as the immune response to such infections is of paramount importance
in furthering our understanding of adenoviral disease as well as to
gauge the immune effects of future adenoviral vaccines such as those
for HIV, tuberculosis, or malaria. We have recently determined that
apes such as chimpanzees, gorillas and orangutans both in captivity
and in the wild frequently shed live adenovirus in their stools [18]; in
the same study, we also confirmed previous estimates [10,19] where
the adenoviruses could be detected in human stools relatively rarely,
i.e., in about 2 to 3% of normal asymptomatic adults. In spite of this
there is a high prevalence of CD4+ and CD8+ gut-associated
lymphocytes that are sensitized to adenoviral antigens [20]. We have,
therefore, undertaken studies to determine whether detection of
adenoviruses in stools is an inadequate surrogate for the assessment of
adenoviral residence in the gut and whether the prevalence of
adenoviruses in the gut is in fact higher than is currently known.
Methods
Isolation of lymphocytes from human gut tissue
Surgically extracted ileum, colon and rectum specimens from
human donors were provided by the Cooperative Human Tissue
Network (CHTN) of the National Institutes of Health. Intestinal
samples obtained at autopsy were obtained from the National
Disease Research Interchange. All ethical procedures with respect to
the protection of human-derived material required for access to
CHTN supplied human tissues and summarized under Policies &
Procedures for the Protection of Human Subjects (http://www.chtn.
nci.nih.gov/access.html) were complied with. In all, intestinal tissue
samples from 58 donors were received and analyzed for this study.
To recover intra-epithelial lymphocytes (IELs), tissue samples were
cut into 0.5-cm squares, washed, and incubated with continuous
agitation inHanks’balanced salt solution containing 5%fetal bovine
serum (FBS) 0.75 mM EDTA, 100 U/ml penicillin, 100 mg/ml
gentamicin, 25 mM HEPES buffer pH 7.4, and (HBSS-EDTA).
The supernatant was removed and used for the isolation of IELs as
described below. For the isolation of lymphocytes from the lamina
propria (LPLs), tissue fragments were cut into 1- to 2-mm pieces and
incubated with continuous agitation for 30 minute intervals in
RPMImedium containing 0.5 mg/mltype IIcollagenase,penicillin,
gentamicin, HEPES buffer, L-glutamine, and 5%FBS. At the end of
eachinterval,intestinalpieces werefurther disruptedbyagitating the
pieces 15 times in a 20-ml syringe. The medium, containing LPLs,
was separated from the remaining tissue fragments by passage
through stainless steel screen cups (mesh size, 40 mm). This process
was repeated two or three times, until the intestinal pieces had
completely dissociated into small fragments. The lymphocyte
population was enriched by discontinuous Percoll (GE Healthcare
Biosciences) density gradient centrifugation which was performed by
diluting isotonic Percoll to 35% (vol./vol.) and to 60% (vol./vol.)
with RPMI and centrifuging the samples at 8006g for 20 min. LPLs
were isolated from the interface between the 35% and 60% layers
and re-suspended in complete RPMI medium. For the isolation of
IELs, the supernatant from the HBSS-EDTA wash was transferred
to a tube and cells washed in RPMI with 5% FBS and stored on ice.
Fresh HBSS-EDTA was added to the intestinal pieces and the
process wasrepeated at leasttwice tillthe supernatant wasclear. The
harvestedcellspresentinthewashwerepooledintoonetube,filtered
through a 40 mm sterile nylon strain, and further purified on a
discontinuous Percoll gradient as described above.
Fractionation of LPLs
Five to ten million LPLs isolated as described above were
fractionated into CD4+ and CD8+ subsets using CD4 or CD8
DynabeadsH (Invitrogen) following the manufacturer’s instruc-
tions. The CD4+-.and CD8+-depleted flow-through fractions were
also collected.
Isolation of DNA and RNA from lymphocytes isolated
from gut tissue
Total cellular DNA and RNA were prepared from tissues or
from LPLs or IELs using the Allprep DNA/RNA isolation kit
purchased from Qiagen (Valencia, CA) following the manufac-
turer’s instructions.
Detection of adenoviral DNA
Intestinal tissue fragments obtained from routine autopsies or
surgical biopsy specimens were used in this study. DNA isolated
from whole tissue fragments, as well as from lymphocytes isolated
from them, was tested for the presence of adenoviral sequences by
a nested PCR technique that amplified a 199 base pair portion of
the adenoviral DNA polymerase gene. Nested PCR primers were
designed to amplify adenoviruses from species A through G. The
outer primers, TGATGCGYTTCTTACCTYTGGTYTCCAT-
GAG and AGTTYTACATGCTGGGCTCTTACCG, amplify a
1.5 kb fragment of the adenoviral DNA polymerase gene
(Figure 1); the products of this PCR reaction were used as tem-
plate for a second round of PCR using the inner primers, GT-
GACAAAGAGGCTGTCCGTGTCCCCGTA and TCACG-
TGGCCTACACTTACAAGCCAATCAC, which amplifies a
258 bp fragment nested within the first product. In every case,
the nested PCR products were cloned and sequenced to confirm
the adenoviral origin of the amplified product. (Usually 2 clones
were sequenced from each cloning experiment unless only one
clone was obtained). The 199 bp sequence between the two
primers was used for sequence comparisons.
Quantitative PCR for the estimation of adenoviral DNA
copies
Genomic DNAs isolated from CD4+ and CD8+ lymphocytes
were subjected to real-time quantitative PCR analysis using the
probe 6FAM-TGGTGGACAACAAGTC-MGBNFQ and the
primers ACAGCATTCGTTACTCGG and CTGTGGTCGT-
TCTGGTAG which amplify a region of the penton-base gene
that is highly conserved across adenovirus species, using HAdV-4
DNA as standard. The total genome copies input into the reaction
was determined in parallel using the probe 6FAM-TCTTACCCT-
CAGCTGGAT-MGBNFQ and the primers AGGAACACTA-
TAGCTCTCTGA and CTGCGCTCATCATGATGGA which
estimates the number of copies of the genomic (X-linked) ornithine
transcarbamylase gene. The determined adenoviral DNA copy
Adenoviruses in Human Intestinal Lymphocytes
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(adjusting as necessary for the sex of the subjects) were used to
calculate adenoviral DNA copies per million diploid genomes.
Reverse transcription PCR for the hexon (L3b) transcript
1 mg of total RNA was used for reverse transcription using the
High Capacity cDNA Reverse Transcription kit from Applied
Biosystems (Carlsbad, CA) in a total volume of 50 ml. Two
microliters of the resulting cDNA was used in a PCR reaction
using the primer ACTBTCTTCCGSATCGCTGT and CTCA-
GGTACTCCGAAGCATCCTG which amplifies an approxi-
mately 300 bp product comprised of the spliced tripartite leader
and the beginning of the hexon coding region.
Sequence analysis
Sequences were aligned using the AlignX module of Vector
NTI software (Invitrogen Inc., Carlsbad, CA) utilizing a neighbor-
joining algorithm of Saitou and Nei [21].
Figure 1. Detection of adenoviral DNA by nested PCR. Top – Diagram showing the region of the adenoviral DNA polymerase gene that was
amplified. Primers designed to hybridize with sequences conserved across species A–F were used to amplify a 1.5 kb region. The product was used as
template for a 2nd round of PCR using similarly conserved primers located internal to the first primer set that amplified a 258 bp product. Bottom –
Agarose gel showing products of the 1st round PCR (upper gel panel) showing positivity (1.5 kb product) in some samples (arrow). The products of
the first round were used for a 2nd nested PCR (lower gel panel).
doi:10.1371/journal.pone.0024859.g001
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Detection of adenoviral DNA in intestinal tissue and
intestinal lymphocytes
Human intestinal tissues obtained during surgery or from
autopsy were tested for the presence of adenoviral DNA using a
nested PCR technique that amplifies a 199 bp segment of the
adenoviral DNA polymerase gene (Figure 1). When the PCR
reaction yielded a product of the correct size, it was cloned and
sequenced. In all, total cellular DNA was extracted from the
intestinal tissue from 58 individual donors which was used as
template for detection of adenoviral DNA. Twenty-one of the
samples were scored as positive based on the sequence of the
amplified DNA. The species of adenovirus that was assigned based
on the sequence is shown in Table 1.
Because mucosal lymphocytes have long been implicated as the
cell types that harbor latent adenovirus [6,8,22,23,24], a subset of
the tissue fragments were used for the isolation of lymphocytes
prior to DNA analysis. Lamina propria lymphocytes (LPLs) and
intra-epithelial lymphocytes (IELs) were isolated as described in
Methods. Total DNA was prepared from the isolated LPLs and
IELs and subjected to nested PCR analysis for the detection of
adenoviral DNA. When positive, the PCR products were cloned
and sequenced and species assigned as before (Table 2). LPLs were
found to be positive more often (21/24) than whole tissue,
indicating that the sensitivity of detection by our nested PCR
technique was higher when DNA from lymphocytes rather than
the whole tissue was used as template.
As mentioned above, 58 total intestinal tissue samples were
received and DNA was extracted from them. In the early part of
our investigation, we found the prevalence of adenoviral DNA in
total tissue DNA to be less than 50%, and this prompted us to test
whether we may be able to improve the sensitivity of detection by
first isolating lymphocytes – IELs and LPLs – from the intestinal
tissues. However, we were not able to successfully isolate sufficient
numbers of IELs/LPLs from every sample, probably relating to
the large differences in sample quality with respect to factors such
as the state of preservation following autopsy or biopsy, the
amount of sample available, the location of the intestine resected
Table 1. Detection of adenoviral DNA in intestinal tissue
fragments.
Donor ID Sex/Age Ad. Species in tissue
1 F/91 E (1)
2 F/60 Negative
3 M/67 E (1)
4 F/53 Negative
5 M/75 E (1), E (4), E (7), E (8)
6 F/73 E (1), B (6)
7 F/63 E, B (6)
8 Negative
9 M/70 E (1)
10 M/68 Negative
11 M/70 Negative
13 M/50 B
14 M/18 Negative
16 F/71 Negative
17 F/35 Negative
18 Negative
20 F/56 Negative
21 F/71 Negative
22 M/42 E
23 F/68 E (2)
24 M/53 E (2)
25 M/57 E (2)
26 M/57 E (2)
27 F/61 Negative
28 E (2)
29 M/60 E (2)
30 M/49 Negative
31 Negative
70 F/57 Negative
71 F-64 Negative
72 F/58 Negative
73 F/56 Negative
74 F/49 Negative
75 F/50 Negative
76 F/78 Negative
77 F/25 Negative
78 F-49 Negative
79 M/57 Negative
80 M/31 F, F (9)
81 F/53 Negative
82 M/44 Negative
83 F/58 Negative
84 M/60 Negative
85 M/80 Negative
86 M/52 E, E
87 F/59 E
88 F/68 E
89 F/70 C, E (11)
Donor ID Sex/Age Ad. Species in tissue
90 F/39 Negative
91 M/60 Negative
92 M/32 E (1)
93 M/69 E (1)
94 M/56 Negative
95 F/68 Negative
96 M/60 Negative
97 F/60 Negative
98 F/61 Negative
99 M/51 Negative
DNAs extracted from intestinal tissue from 58 donors were tested for the
presence of adenoviral DNA by nested PCR. The sex (M/F) and age of the donor
at the time of biopsy or autopsy is shown. When positive, the 199 bp sequence
of the adenoviral DNA polymerase gene that was amplified was used to assign
the species shown. The ‘‘sequence type’’ is shown in parenthesis after the
assigned species in case of sequences isolated more than once and corresponds
to the ‘‘sequence types’’ shown in Figure 2.
doi:10.1371/journal.pone.0024859.t001
Table 1. Cont.
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However when it became clear that a high proportion of gut
lymphocytes we did analyze (particularly LPLs) were positive for
adenoviral DNA, we additionally isolated RNA from the last 12
intestine samples that we received. Samples from which we were
able to recover at least 1 mg of total RNA (11 donors) were
subjected to RT-PCR for the presence of adenoviral transcripts, as
described below.
In all, adenoviral DNA was successfully amplified from 39
different donors and 41 non-identical sequences were obtained.
The sequences that were obtained were assigned to an adenoviral
species by comparing the sequence with human adenovirus
sequences (from species A, B, C, D, E, F and G) employing the
neighbor joining algorithm of Saitou and Nei [21] using Vector
NTI software. The alignments derived from this analysis are
shown in Figure 2. Only one donor harbored sequences that were
related to species F (HAdV-40 or 41), which can usually be
causally related to infectious diarrhea [25]. HAdV-A or HAdV-D
sequences have not been detected by us to date. A majority of the
sequences clustered with HAdV-4, the only human species E
adenovirus for which a full sequence in available. However it is
interesting to note that only 6 of the sequences were clearly very
closely related to the canonical species E (i.e., HAdV-4) sequence,
and only one was identical. Alignments of the sequences that were
assigned to belong to species B, C and E respectively are shown in
Figure 2.
It can be seen from the data shown on Table 1, Table 2 and
Figure 2 that it was common to identify multiple sequences
including those belonging to different species from the same
donor. A large amount of tissue obtained at autopsy was made
available to us from two donors (donors number 5 and 13). Donor
5 was a 75 year old white male who had died following a stroke.
We performed nested PCR analysis on several tissue fragments
from the ileum and colon as well as LPLs derived from those tissue
fragments. We were able to identify nine non-identical sequences
from this donor, all belonging to species E (Figure 3). Similarly
donor 13 (a fifty year old white male who had died following
myocardial infarction) yielded multiple sequences belonging to
species E as well as one sequence that could be assigned to species
B (Figure 3). Phylogenetic relationships of the sequences isolated
from either donor are also shown in Figure 3.
Detection and quantification of adenoviral DNA in
fractionated lymphocytes
The cell type that has most often been shown to be a likely site
for latent adenoviruses is the T lymphocyte [6,8,9,22,23,24]. We
wished to confirm that adenovirus DNA was present in the T
lymphocyte fraction of the cells isolated from lamina propria and
at the same time to test whether the adenoviral DNA was equally
present in CD4+ and CD8+ cells. In order to do this, LPLs from
14 different subjects were fractionated into CD4+ and CD8+
subsets using antibody coated magnetic beads and total cellular
DNA was extracted from them. A real-time PCR method was used
to quantify the number of adenoviral DNA copies that were
present in unfractionated lymphocytes (total LPLs) as well as the
CD4+ and CD8+ fractions (Figure 4). The DNA copy numbers
ranged from about a hundred to about half a million (per million
cells) in the unfractionated LPLs; the fractionated lymphocytes
harbored from a few hundred to as many as 3 million adenoviral
DNA copies per million cells on average. In 12 of 14 samples, the
copy numbers in the fractionated lymphocytes was higher than the
copy numbers in the corresponding unfractionated samples (data
not shown) indicating that the T lymphocytes present in the LPL
population preferentially harbored adenoviral DNA; also, it was
seen that adenoviral DNA was equally likely to be present in
CD4+ or CD8+ lymphocytes.
Detection of active adenoviral transcription
Finally, we wished to determine whether the adenoviral DNAs
that we could detect in the gut lymphocytes were in the process of
being actively transcribed. LPLs and IELs were isolated from the
intestinal tissue of 11 donors and total RNA was prepared from
them. We attempted to detect the presence of the early region E1a
transcripts using reverse transcription followed by PCR (RT-
PCR). Because there were insufficient sequence identities in the
E1a regions of different species of adenoviruses, we designed
separate primer sets to detect E1a transcripts for species B, C, and
E adenoviruses. However we were unable to detect E1 transcripts
in any RNA sample, probably because transcript copy numbers
were too low to be detected by our assay. Because transcripts from
the adenoviral major late promoter are very abundant in
replicating cells, we next designed primers to detect the spliced
Table 2. Detection of adenoviral DNA in intestinal
lymphocytes.
Donor ID Sex/Age Adenovirus Species (sequence type)
Tissue IELs LPLs
1 F/91 E (1) E (1) E
2 F/60 Negative E (1) C
3 M/67 E (1) C (5) C (5)
4 F/53 Negative E (1) E (4)
5 M/75 E (1), E (4), E (7), E (8) Not tested E, E, E, E, E, E (1)
6 F/73 E (1), B (6) E (4), B (6) Negative
7 F/63 E, B (6) C (5), B (6) Negative
8 Negative E (7) E (7)
9 M/70 E (1) E (8) C, E (1)
10 M/68 Negative Negative C, E
11 M/70 Negative Negative E (1)
12 F/37 Not tested Negative Negative
13 M/50 B E (1) E, E, E, E (1), E (2)
14 M/18 Negative E C
15 F/18 Not tested Not tested B, E (2)
17 F/35 Negative Negative E, E, E (1)
18 Negative Negative E
20 F/56 Negative Negative E, E, E (1) E (10)
21 F/71 Negative E (1) E (2), E (10)
85 M/80 Negative Not tested C (5)
86 M/52 E, E B (3) B
90 F/39 Negative Not tested B (3)
92 M/32 E (1) Not tested B (3)
94 M/56 Negative Not tested B (3)
DNAs from intra-epithelial lymphocytes (IELs) and lamina propria lymphocytes
(LPLs) from 24 donors were tested for the presence of adenoviral DNA by
nested PCR. The sex (M/F) and age of the donor at the time of biopsy or
autopsy is shown. When positive, the sequence of the adenoviral DNA
polymerase gene that was amplified was used to assign the species shown (the
result of the analysis of whole tissue DNA is also shown). All the identified
sequences from any particular individual sample are indicated. The ‘‘sequence
type’’ is shown in parentheses after the assigned species in case of sequences
isolated more than once and corresponds to the ‘‘sequence types’’ shown in
Figure 2.
doi:10.1371/journal.pone.0024859.t002
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assay was designed to detect processed mRNA since the primers
spanned introns and the PCR product corresponded to the size
expected of fully processed mRNA. This also precluded the
artefactual detection of adenoviral genomic DNA. We were
successful in amplifying and sequencing the L3b late transcript in
RNA from 9 of the 11 donors that were tested (Figure 5).
Sequences that could be assigned to species B, C, and E could be
identified; some samples yielded more than one kind of sequence,
e.g., three different sequences could be identified in RNA from
donor 38.
Discussion
Persistent enteral infections with adenoviruses following resolu-
tion of upper respiratory tract infections (symptomatic or not) in
infants and children have been well documented [1,2]. Up to 15%
of cases were found to excrete adenovirus in the stools for periods
ranging from 3 months to a year following the initial infections;
about a third of these continued to excrete virus for even longer
periods. Furthermore many of these cases exhibited intermittent
excretion confirmed to be due to recrudescence rather than re-
infection [2,26], implying periods of suppressed viral replication.
While it is clear that adenoviral infections of the upper respiratory
tract leads to fecal virus excretion, Adrian et al. [26] speculated
that the location of the persistent infection could be the intestinal
epithelium or Peyer’s patches. In this communication we have
directly tested intestinal tissue for the presence of adenoviral DNA
and found that intestinal tissue, particularly lymphocytes isolated
from intestinal tissues, can frequently be found to harbor
adenoviral DNA. In contrast, DNA from respiratory inflammatory
exudates, such as from patients with chronic obstructive
pulmonary disease, are only infrequently positive for the presence
of adenoviral sequences [27].
Adenoviruses have long been known establish persistent
infections in adenoidal and tonsillar tissue as evidenced by
Figure 2. Alignments of the amplified 199 bp sequences contained internal to the primers of the 258 nested PCR products. The
donor from whom each sequence was identified (as described in Tables 1 and 2) is indicated and corresponds to donor numbers in Tables 1 and 2.
(The letter following the donor number identifies the source of the DNA used for analysis: T- intestinal tissue, L- LPLs, L*- IELs. All sequences were
assigned to one of four adenoviral species, (HAdV-B, HAdV-C, HAdV-E, or HAdV-F) using the neighbor-joining algorithm of Saitou and Nei [21] and the
resulting alignments with one of the reference HAdV species (red font) is shown. Regions of identity across all sequences are shaded yellow; regions
that are common to the majority of sequences are shaded blue. Sequences that were obtained more than once were assigned to one of 11
‘‘sequence types’’. The donor sample that yielded each sequence type is shown in the table.
doi:10.1371/journal.pone.0024859.g002
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adenoviral DNA [7,8]. When outgrowth in culture is successful,
replication isseen to occur infibroblastsor epithelial cells.However,
the cell types that are now implicated to be the persistent carriers of
adenoviruses in the tonsils and adenoids are lymphocytes where the
adenoviral genome is presumed to be latent but capable of
productive replication when stimulated with mitogens [9]. A similar
re-activation is presumed to occur in immunocompromised states
such as in transplant recipients where adenoviral viremia is a
recognized complication [12,13]. It has been recognized that
although lymphocytic and macrophage cell lines can be infected
with adenovirus, in contrast to epithelial cells or fibroblasts, a lytic
infection often does not occur [23,24,28,29,30]. A persistent
infectious state can be established in such cell lines with continuous
low-level viral replication. Although we wereable to detect late gene
expression inmost of thesamplesthat we tested,we have so farbeen
unable to recover live adenovirus from LPLs even after stimulating
by various means; viz., with phytohemagglutinin, with phorbol
myristate acetate in conjunction with ionomycin, or with a
combination of anti-CD3 and anti-CD28 antibodies respectively
(data not shown). This may be due to T cells being intrinsically
resistant to viral replication as has been shown to be the case with
humanT celllines[30].Ithasbeenpreviouslynotedthatevenwhen
adenoviral replication can be demonstrated in primary T cells from
the adenoids or tonsils, they appear to be considerably attenuated in
their capacity to initiate a typical cytopathic effect in culture [9]. It is
possible that this is the case with adenoviruses from the gut as well.
In our quantitative PCR assays we determined the adenovirus
copy numbers in gut lymphocytes ranged from a few hundred to
several million per million cells. Similar copy number were reported
for lymphocytes from adenoids and tonsils [9]; these investigators
found that even in samples with very high adenovirus copy
numbers, the actual numbers of cells harboring viral DNA (as
determinedbya limitingdilutionassay)rangedfromlessthan onein
a million to one in a thousand. Although we have not determined
this, we expect the same to be true for gut lymphocytes.
Although we have found that adenoviral DNA and adenoviral
transcripts can easily be detected in intestine-derived lymphocytes,
we and others have found that the frequency with which
adenoviruses can be cultured from stools of normal human subjects
is only about 2 to 3% [10,18,19] with the exception of subjects in
recent contact with clinically ill adenovirus-infected patients,
principally children, as first reported by Fox et al. [1,2]. This is
clearly different from the situation in both great apes and monkeys
where shedding of live adenoviruses is easily detected [18]. Whether
this reflects a difference in the immunological milieu between apes
and monkeys on the one hand and humans on the other,or whether
this is a consequence of the differences in the specific types of
colonizing adenoviruses needs to be determined.
The frequent and facile demonstration of adenoviral DNA in
lymphocytes of the adenoids and tonsils contrasted with the
Figure 3. Two instances of multiple adenoviral DNA sequences amplified from a single donor. Sequences amplified from donors 5 and
13 and the source of the DNA from which sequences were amplified is shown in the tables. The phylogenetic relationships between these sequences
as computed using the nearest neighbor algorithm of Saitou and Nei [21] is also shown. The calculated distance value for each sequence is shown in
parentheses (Vector NTI, AlignX module).
doi:10.1371/journal.pone.0024859.g003
Figure 4. Copy numbers of adenovirus DNA (per million
diploid genomes) detected by quantitative PCR in lamina
propria lymphocyte (LPLs). Data for unfractionated (total LPLs) as
well as CD4+ and CD8+ fractionated lymphocytes are shown. Each data
point represents a single sample. The mean and standard deviation for
each data set are indicated.
doi:10.1371/journal.pone.0024859.g004
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raises the question whether this apparent compartmentalization of
lymphocytes extends to other peripheral lymphoid organs. We
now show that the T cells of the sub-mucosa of the ileum, rectum
and colon are also colonized by adenoviruses which may be seen
to be part of the normal flora. It would be important to test
whether circulating PBMCs do in fact harbor adenoviral genomes
less frequently than lymphocytes that home to the gut, preferably
using samples from both locations in the same individual.
There appears to be a remarkable diversity of adenovirus
sequences that can be recovered by PCR, including those
belonging to species E that are different from the only readily
isolated species E adenovirus – HAdV-4. The part of the
adenovirus genome that was amplified and sequenced corresponds
to the amino-acid residues 944–1009 of the HAdV-5 DNA
polymerase, a 1198-residue protein. Over this segment the degree
of intra-species sequence DNA sequence variation among
sequenced human adenoviruses is very low. For instance there is
100% DNA sequence identity between the two sequenced species
B1 human adenoviruses HAdV-3 and HAdV-7 and between the
HAdV-B2 adenoviruses HAdV-11 and HAdV-35; only a 2-base
difference is seen between the three HAdV-C adenoviruses
(HAdV-1, HAdV-2, and HAdV-5). The DNA sequences that
were identified in this study varied much more; for example
among the five kinds of sequences identified that could be assigned
to HAdV-B1 (13T, type 3, type 6, 86L* and 86L, Figure 2), we
were able to detect 14 nucleotide differences from the reference
HAdV-3 sequence (of which 8 were silent, data not shown). A
similar degree of sequence diversity is also seen in the species C
and species E sequences as well (Figure 2).
Although we have isolated a diverse array of sequences from
human lymphocytes, we have also seen that it is common for a
Figure 5. Detection of the adenoviral transcription. RNA was isolated from IELs and LPLs from 11 subjects (table, upper left) and subjected to
reverse transcription followed by PCR. The adenoviral L3b transcript (shown in green in the diagram, upper right; hexon orf shown in orange) harbors
a tri-partite leader comprised of three widely separated leader exons followed by the last exon encoding the hexon protein. The PCR primers (as
shown by arrowheads) were designed to hybridize to conserved sequences in the first leader and to the last exon. The approximately 300 base-pair
product from reactions that were positive were cloned and sequenced. The sequences obtained from the different samples were assigned to
adenoviral species B, C, or E (table) and aligned to a reference adenovirus sequence (HAdV-7, HAdV-2, and HAdV-4, respectively) for each species.
Regions of identity across all sequences are shaded yellow; regions that are common to the majority of sequences are shaded blue. The exon
boundaries are indicated by vertical lines. The putative hexon start codon is indicated by an arrow below the alignments. One of the species B
sequences (sequence 48-2) contains a second leader that represents an alternate splicing pattern from that seen with the other sequences.
doi:10.1371/journal.pone.0024859.g005
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including at least two individuals from whom we recovered
multiple sequences as shown in Figure 3. However we have not
systematically addressed the question of how common of an
occurrence this may be, and whether these two individuals are
more typical of the normal population than not.
We have also demonstrated that expression of adenoviral late
genes is easily detected even though viral replication is likely to
only occur at fairly low levels. We and others have shown that T
cells with cross-reactivity across serotypes can be demonstrated in
normal subjects [20,31,32]. The continuous low-level exposure to
adenoviral antigens resulting from this smoldering viral infection
may help explain the fairly widespread occurrence of T cells
reactive to adenoviral antigens such as the hexon protein.
Furthermore, the absence of florid viral replication may explain
the generally low antibody titers that are normally seen in adult
population [20,33] compared to the titers that are observed
following adenovirus infection [34,35] or following adenovirus
administration for immunization [36,37]. It can be speculated that
infected T cells should themselves be targets for cytotoxic cells; it
would be of interest to determine whether adenoviral genes such as
those expressed from early region E3 can influence this process
and whether the expression profile of genes from the E3 region
may be different in lymphoid cells than in somatic cells.
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